$Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists$

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

Saved in:

Bibliographic Details
Main Authors:	Monica Carpenedo, Arianna Zappaterra, Beatrice Ferrari, Giulia Cotilli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2023-02-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Chronic ITP ITP thrombopoietin new agents New Drugs Refractory ITP
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/5240
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of Immunosuppression, Romiplostim, and Splenectomy to Achieve Remission in a British Shorthair Cat With Primary Immune‐Mediated Thrombocytopenia
by: Josh M. Kennils, et al.
Published: (2025-07-01)

PATIENTS WITH ≥ 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE
by: Simone Baldini, et al.
Published: (2012-06-01)

Stimulation of platelet production: the new treatment approach to chronic immune thrombocytopenic purpura
by: A. A. Maschan, et al.
Published: (2022-11-01)

CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
by: E. A. Pyadushkina, et al.
Published: (2016-02-01)

Platelet Satellitism in a Patient with Underlying Infection, Immune Thrombocytopenic Purpura (ITP) and Multiple Sclerosis
by: Athanasios Liaskas, et al.
Published: (2025-05-01)

Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy
by: Konstantina Salveridou, et al.
Published: (2024-09-01)

Response and remission after first-line corticosteroid therapy in primary immune thrombocytopenia
by: D Mapimhidze, et al.
Published: (2025-02-01)

PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC
by: Francesco Rodeghiero
Published: (2021-04-01)

When the Breather Bleeds and the Bleeder Strives – A Rare Manifestation of an Unrare Disease
by: B Drishya Appachu, et al.
Published: (2024-11-01)

Urogenital haemorrhage secondary to Babesia gibsoni induced immune thrombocytopenia and its management with combination of romiplostim and prednisolone in a dog
by: Nadima Khan, et al.
Published: (2025-06-01)

Gut microbiota pattern in children and adolescents with newly diagnosed immune thrombocytopenia
by: Mohsen Elalfy, et al.
Published: (2025-07-01)

Correlation between Serum Levels of Some Immunological Biomarkers and Severity of Idiopathic Immune Thrombocytopenia
by: Ola A. Hashim, et al.
Published: (2025-06-01)

A retrospective study of risk factors for thrombosis in patients with ITP
by: Fan Zhou, et al.
Published: (2025-12-01)

Immune thrombocytopenia in Kabuki syndrome, a comparison with non-Kabuki cases in the UK paediatric ITP registry
by: Lianna Reynolds, et al.
Published: (2025-05-01)

Thiol / disulfide balance and oxidative stress parameters in pediatric patients diagnosed with acute and chronic idiopathic thrombocytopenic purpura
by: Yeter Düzenli Kar, et al.
Published: (2021-12-01)

The metabolism-immunity axis in Immune thrombocytopenia: from energy regulation to targeted therapy
by: Xin Zhou, et al.
Published: (2025-07-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination
by: Emilie C. Collins, et al.
Published: (2021-10-01)

MATHEMATICAL MODELS FOR THE PREDICTION OF THE ENCAPSULATION BEHAVIOR IN FOOD SYSTEMS
by: Iuliana Vinitila
Published: (2010-07-01)

Guidelines of Russian Expert Council on diagnostic and therapy of patients with primary immunne thrombocytopenia
by: A. A. Maschan, et al.
Published: (2022-11-01)

Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports
by: Waleed Ghanima, et al.
Published: (2025-12-01)

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag
by: Antonella Sau, et al.
Published: (2025-04-01)

Short Term Outcome of High Dose Dexamethasone Versus Prednisone In Children With Acute Immune Thrombocytopenic Purpura: A Single Center Trial
by: Ahmed Osama Kaddah, et al.
Published: (2025-01-01)

Real-world experience of hetrombopag in immune thrombocytopenia treatment: a retrospective cohort study
by: Dan Wang, et al.
Published: (2025-07-01)

Toll-like receptor 7 single nucleotide polymorphism rs3853839 in pediatric patients with immune thrombocytopenia
by: Junlin Wang, et al.
Published: (2025-07-01)

Dynamic changes in platelet counts and psychological state in ITP patients after COVID-19 infection
by: Xiaoli Chen, et al.
Published: (2025-03-01)

The Differences between Pre- and Post-Therapy Levels of Platelet Count and Platelet Indices in Children with Immune Thrombocytopenia Purpura
by: Regina Rania Cahya Kusumaningrum -, et al.
Published: (2024-12-01)

Late but effective and durable response to splenectomy in a patient with very 20 years-lasting immune thrombocytopenia and thrombophilic diathesis.
by: Pasquale Niscola
Published: (2014-08-01)

The Kongming defense: Host-pathogen battles take a new face
by: Dongchun Ni
Published: (2025-06-01)

INVASIVE TERRESTRIAL PLANT SPECIES IN THE ROMANIAN PROTECTED AREAS. A GEOGRAPHICAL APPROACH
by: MONICA DUMITRAŞCU, et al.
Published: (2015-12-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2017-11-01)

The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches
by: Xuejun Guo, et al.
Published: (2025-06-01)

A case study of an international teaching practicum program in Thailand: Indonesian EFL teacher trainees’ teaching strategies, challenges, and intercultural sensitivity level
by: Andi Rustandi, et al.
Published: (2025-03-01)

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report
by: Kouki Hoshino, et al.
Published: (2019-04-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01)

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
by: O. Yu. Vinogradova, et al.
Published: (2024-12-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study
by: Xijuan Lin, et al.
Published: (2025-12-01)

Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01)